# Market Saturation

From Gold Mine to Glut: The Darkest Hour for China’s HPV Vaccine Giants

China's leading HPV vaccine manufacturers, Wantai and Zhifei, have reported record financial losses as the market shifts from scarcity to a massive oversupply. A combination of high vaccination rates among wealthy demographics and aggressive government price-cutting has collapsed profit margins, forcing a difficult strategic pivot.